Your browser doesn't support javascript.
loading
The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model.
Choi, Soo In; Kim, Nayoung; Nam, Ryoung Hee; Jang, Jae Young; Kim, Eun Hye; Ha, SungChan; Kang, Kisung; Lee, Wonseok; Choi, HyeLim; Kim, Yeon-Ran; Seok, Yeong-Jae; Shin, Cheol Min; Lee, Dong Ho.
Afiliação
  • Choi SI; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim N; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Nam RH; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Jang JY; Department of Medical Device Development, Seoul National University College of Medicine, Seoul, Korea.
  • Kim EH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Ha S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kang K; Department of Medical Device Development, Seoul National University College of Medicine, Seoul, Korea.
  • Lee W; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Choi H; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim YR; Bio Bank Healing, Seongnam, Korea.
  • Seok YJ; Bio Bank Healing, Seongnam, Korea.
  • Shin CM; Department of Biological Sciences and Institute of Microbiology, Seoul National University, Seoul, Korea.
  • Lee DH; Department of Biological Sciences and Institute of Microbiology, Seoul National University, Seoul, Korea.
J Cancer Prev ; 28(3): 93-105, 2023 Sep 30.
Article em En | MEDLINE | ID: mdl-37830115
ABSTRACT
Roseburia faecis, a butyrate-producing, gram-positive anaerobic bacterium, was evaluated for its usefulness against repeated water avoidance stress (WAS)-induced irritable bowel syndrome (IBS) in a rat model, and the underlying mechanism was explored. We divided the subjects into three groups one without stress exposure, another subjected to daily 1-hour WAS for 10 days, and a third exposed to the same WAS regimen while also receiving two different R. faecis strains (BBH024 or R22-12-24) via oral gavage for the same 10-day duration. Fecal pellet output (FPO), a toluidine blue assay for mast cell infiltration, and fecal microbiota analyses were conducted using 16S rRNA metagenomic sequencing. Predictive functional profiling of microbial communities in metabolism was also conducted. FPO and colonic mucosal mast cell counts were significantly higher in the WAS group than in the control group (male, P = 0.004; female, P = 0.027). The administration of both BBH024 (male, P = 0.015; female, P = 0.022) and R22-12-24 (male, P = 0.003; female, P = 0.040) significantly reduced FPO. Submucosal mast cell infiltration in the colon showed a similar pattern in males. In case of fecal microbiota, the WAS with R. faecis group showed increased abundance of the Roseburia genus compared to WAS alone. Moreover, the expression of a gene encoding a D-methionine transport system substrate-binding protein was significantly elevated in the WAS with R. faecis group compared to that in the WAS (male, P = 0.028; female, P = 0.025) group. These results indicate that R. faecis is a useful probiotic for treating IBS and colonic microinflammation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article